TSXV:TRL.H - Post by User
Comment by
Chuckleeon Jun 07, 2018 11:47am
133 Views
Post# 28139795
RE:Sorry to see him go.
RE:Sorry to see him go.I dont think the market reaction is all due to him stepping down, it probably has more to do with share dilution.
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company”) (TSX:ASP) is pleased to announce that it has entered into a revised agreement with Mackie Research Capital Corporation (the “Underwriter”), to increase the size of the previously announced bought deal short form prospectus offering (the "Offering") to $5,750,010 of units ("Units") of the Company, at a price of $0.30 per Unit (the "Offering Price")